Skip to main content
Clinical Trials/NCT05554653
NCT05554653Active, not recruitingNot Applicable

Influence of Leucine Enriched Amino Acids on Myofibrillar and Collagen Protein Synthesis in Human Skeletal Muscle

Daniel Moore1 site in 1 country8 target enrollmentStarted: October 1, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
8
Locations
1
Primary Endpoint
Myofibrillar Protein synthesis

Study Overview

Brief Summary

The primary objective will be to determine the effect of leucine-enriched essential amino acids (LEAA) compared to carbohydrate placebo on dietary incorporation of [D5] Phenylalanine & [D5] Glycine into the three skeletal muscle protein pools (myofibrillar, sarcoplasmic and collagen), both following resistance exercise and at rest, with the two tracers provided as a 'intrinsically labeled' bolus. Other outcomes will relate to molecular regulation of protein synthesis.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Masking Description

Double blinded (investigators and participants). A lab member external to the investigation will code items for the intervention.

Eligibility Criteria

Ages
18 Years to 35 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Healthy, male and female, recreationally-active participants.
  • •Healthy will be defined as screened by the PAR-Q+ (The Physical Activity Readiness Questionnaire for everyone; Appendix B).
  • •Self-reported not having engaged in resistance exercise and/or lower body plyometrics for at least 3 months prior to the study.
  • •Participants will be aged 18-35 years old.
  • •Participants are willing to abide by the compliance rules of this study.
  • •Self-reported regular menstrual cycle (25-35d) within the last 3 months (female participants).

Exclusion Criteria

  • •Inability to adhere to any of the compliance rules judged by principle investigator or medical doctor.
  • •Self-reported regular tobacco use.
  • •Self-reported illicit drug use (e.g. growth hormone, testosterone, etc.).
  • •Individuals who have participated in studies within the past year involving any of the stable isotopes in the study.
  • •Use of birth control and discontinued use within the last 3 months (female participants).

Arms & Interventions

Leucine enriched essential amino acids

Active Comparator

Leucine enriched essential amino acids (4g total, of which 1.6g are leucine). 20g carbohydrate, 2g of protein free drink powder, and 5g of Splenda to mask taste.

Intervention: Leucine enriched amino acids (Dietary Supplement)

Carbohdyrate Placebo

Placebo Comparator

Iso-caloric placebo (4g maltodextrin to replace LEAA). 20g carbohydrate, 2g of protein free drink powder, and 5g of Splenda to mask taste.

Intervention: Carbohydrate Placebo (Dietary Supplement)

Outcomes

Primary Outcomes

Myofibrillar Protein synthesis

Time Frame: 4 hours

Rate of incorporation of orally ingested amino acid tracers (D5 Phe and D5 Gly) into myofibrillar proteins isolated from skeletal muscle biopsies 4h following drink (LEAA or PLA) consumption and resistance exercise or at rest. Enrichment will be quantified via tandem LC-MS/MS to derive a rate of incorporation over the 4h period.

Secondary Outcomes

  • Collagen protein synthesis(4 hours)
  • Sarcoplasmic protein synthesis(4 hours)
  • Protein localization via immunofluorescence(4 hours)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Daniel Moore

Associate Professor

University of Toronto

Study Sites (1)

Loading locations...

Similar Trials

Influence of Leucine Enriched Amino Acids... | Clinical Trial